Related Experiment Videos
Oestrogen regulated gene expression in normal and malignant endometrial tissue
Sharon A O'Toole1, Elizabeth Dunn, Brian L Sheppard
1Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre, St. James's Hospital, Dublin 8, Ireland. shotoole@tcd.ie
Maturitas
|May 27, 2005
Summary
Oestrogen receptor alpha (ERa) and progesterone receptor (PR) are key in normal and malignant endometrium. Normal tissues show higher ERa, PR, and IGF-1 levels than cancerous ones, suggesting their role in endometrial carcinogenesis.
Area of Science:
- Endocrinology
- Molecular Biology
- Gynecologic Oncology
Background:
- The molecular mechanisms of oestrogen-regulated genes in endometrial carcinogenesis are not fully understood.
- Investigating these genes is crucial for understanding endometrial cancer development.
Purpose of the Study:
- To examine oestrogen-regulated gene expression in normal and malignant endometrial tissues from premenopausal and postmenopausal women.
- To elucidate the role of these genes in endometrial carcinogenesis.
Main Methods:
- Analysis of mRNA expression levels of oestrogen receptor alpha (ERa), oestrogen receptor beta (ERb), progesterone receptor (PR), insulin-like growth factor 1 (IGF-1), and vascular endothelial growth factor (VEGF).
- Real-time TaqMan PCR was employed on 60 endometrial specimens.
Main Results:
- ERa was more prevalent than ERb; 28% of samples lacked ER expression.
- Normal endometrial tissues exhibited higher ERa, PR, and IGF-1 expression than malignant tissues.
- ERa and PR expression were significantly higher in the proliferative phase compared to the secretory phase (P < 0.05).
- PR mRNA expression strongly correlated with ERa across all tissue types.
Conclusions:
- ERa likely plays a significant role in regulating PR in both normal and malignant endometrium.
- Further research is required to determine the role of IGF-1 in specific endometrial cancers.
- The involvement of VEGF isoforms in endometrial cancer warrants additional investigation.